Medicine combination with antitumor activity
A technology of anti-tumor activity and composition, applied in anti-tumor drugs, drug combinations, organic active ingredients, etc., can solve the problem that DMXAA is unlikely to be clinically useful
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] Example 1 Synergistic Combination of DMXAA and Pingyangmycin
[0058] Material:
[0059] Cell lines: human lung cancer A549 cells and liver cancer SMMC-7721 cells
[0060] Preparation of test drugs: DMXAA was dissolved with 5% sodium bicarbonate before use, and then made into the required concentration with RPMI1640 culture solution; Pingyangmycin (PYM) was dissolved with normal saline before use, and then made into the required concentration with RPMI1640 culture solution .
[0061] Cell culture:
[0062] Inoculate human lung cancer A549 cells and liver cancer SMMC-7721 cells into sterile culture flasks, add appropriate amount of RPMI1640 culture medium, and incubate at 37°C, 5% CO 2 cultured in an incubator with saturated humidity. The cells grow purely adherent and are passaged every 2-3 days. Digest with 3g / L trypsin for 1min during subculture, pipette with culture medium to make cell suspension, and inoculate according to the required concentration.
[0063...
Embodiment 2
[0086] Example 2 Synergistic combination of DMXAA and actinomycin D
[0087] Material:
[0088] Cell lines: human lung cancer A549 cells and liver cancer SMMC-7721 cells
[0089] Preparation of test drugs: DMXAA was dissolved with 5% sodium bicarbonate before use, and then made into the required concentration with RPMI1640 culture solution; actinomycin D was dissolved in normal saline before use, and then made into the required concentration with RPMI1640 culture solution.
[0090] Cell culture:
[0091] Inoculate human lung cancer A549 cells and liver cancer SMMC-7721 cells into sterile culture flasks, add appropriate amount of RPMI1640 culture medium, and incubate at 37°C, 5% CO 2 cultured in an incubator with saturated humidity. The cells grow purely adherent and are passaged every 2-3 days. Digest with 3g / L trypsin for 1min during subculture, pipette with culture medium to make cell suspension, and inoculate according to the required concentration.
[0092] method:...
Embodiment 3
[0115] Example 3 Synergistic combination of DMXAA and mitomycin (MMC)
[0116] Material:
[0117] Cell lines: human lung cancer A549 cells and liver cancer SMMC-7721 cells
[0118] Preparation of test drugs: DMXAA was dissolved with 5% sodium bicarbonate before use, and then made into the required concentration with RPMI1640 culture solution; mitomycin (MMC) was dissolved with normal saline before use, and then made into the required concentration with RPMI1640 culture solution. concentration.
[0119] Cell culture:
[0120] Inoculate human lung cancer A549 cells and liver cancer SMMC-7721 cells into sterile culture flasks, add appropriate amount of RPMI1640 culture medium, and incubate at 37°C, 5% CO 2 cultured in an incubator with saturated humidity. The cells grow purely adherent and are passaged every 2-3 days. Digest with 3g / L trypsin for 1min during subculture, pipette with culture medium to make cell suspension, and inoculate according to the required concentrat...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
